Skip to main content

Table 3 The expression of hTid and ErbB-2 is inversely correlated in primary breast cancer (A) and in non mammary tumors (B).

From: In vivo evidence of htid suppressive activity on ErbB-2 in breast cancers over expressing the receptor

A1

hTid (+)

hTid (-)

B2

hTid (+)

hTid (-)

ErbB-2 (+)

2*

22*

ErbB-2 (+)

2*

8*

ErbB-2 (-)

28*

6*

ErbB-2 (-)

8*

0*

  1. *: number of cases; 1: p< 0,0001; 2: p< 0,007;